Overexpression or amplification of HER2 is implicated in several types of cancers, most notably breast cancer. HER2-positive breast cancer is characterized by an overabundance of HER2 receptors on the surface of tumor cells, leading to rapid cell growth and division. This overexpression is typically identified through immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) techniques.
